These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25427660)

  • 1. The low level of glucagon-like peptide-1 (glp-1) is a risk factor of type 2 diabetes mellitus.
    Lastya A; Saraswati MR; Suastika K
    BMC Res Notes; 2014 Nov; 7():849. PubMed ID: 25427660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes.
    Manell H; Staaf J; Manukyan L; Kristinsson H; Cen J; Stenlid R; Ciba I; Forslund A; Bergsten P
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1181-9. PubMed ID: 26745255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The changes of gastrointestinal hormones GLP-1, PYY and ghrelin in patients with newly diagnosed type 2 diabetes mellitus].
    Cui T; Ren Y; Ma H; Liu SF; Zhang XX; Yu HL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):774-8. PubMed ID: 24325110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
    Knop FK; Aaboe K; Vilsbøll T; Vølund A; Holst JJ; Krarup T; Madsbad S
    Diabetes Obes Metab; 2012 Jun; 14(6):500-10. PubMed ID: 22171657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired secretion of glucagon-like peptide 1 during oral glucose tolerance test in patients with newly diagnosed type 2 diabetes mellitus.
    Wang XL; Ye F; Li J; Zhu LY; Feng G; Chang XY; Sun K
    Saudi Med J; 2016 Jan; 37(1):48-54. PubMed ID: 26739974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of GLP-1 induced glucagon suppression in type 2 diabetes mellitus.
    Hare KJ
    Dan Med Bull; 2010 Sep; 57(9):B4181. PubMed ID: 20816021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting and stimulated glucagon-like peptide-1 exhibit a compensatory adaptive response in diabetes and pre-diabetes states: A multi-ethnic comparative study.
    Chong SC; Sukor N; Robert SA; Ng KF; Kamaruddin NA
    Front Endocrinol (Lausanne); 2022; 13():961432. PubMed ID: 36157456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of exogenous hyperglucagonemia on postprandial concentrations of gastric inhibitory polypeptide and glucagon-like peptide-1 in humans.
    Meier JJ; Ritter PR; Jacob A; Menge BA; Deacon CF; Schmidt WE; Nauck MA; Holst JJ
    J Clin Endocrinol Metab; 2010 Aug; 95(8):4061-5. PubMed ID: 20501678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting and post-prandial glucagon like peptide 1 and oral contraception in polycystic ovary syndrome.
    Aydin K; Arusoglu G; Koksal G; Cinar N; Aksoy DY; Yildiz BO
    Clin Endocrinol (Oxf); 2014 Oct; 81(4):588-92. PubMed ID: 24730585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incretin and glucagon levels in adult offspring exposed to maternal diabetes in pregnancy.
    Kelstrup L; Clausen TD; Mathiesen ER; Hansen T; Holst JJ; Damm P
    J Clin Endocrinol Metab; 2015 May; 100(5):1967-75. PubMed ID: 25781355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of transoral gastroplasty on glucose homeostasis in obese subjects.
    Leccesi L; Panunzi S; De Gaetano A; Familiari P; Iaconelli A; Guidone C; Mazzarella A; Costamagna G; Mingrone G
    J Clin Endocrinol Metab; 2013 May; 98(5):1901-10. PubMed ID: 23543657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between metabolic syndrome and meal-induced glucagon like peptide-1 response in type 1 diabetic patients1-1.
    Blaslov K; Bulum T; Zibar K; Duvnjak L
    J Diabetes; 2015 May; 7(3):340-6. PubMed ID: 25042812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary impact on fasting and stimulated GLP-1 secretion in different metabolic conditions - a narrative review.
    Huber H; Schieren A; Holst JJ; Simon MC
    Am J Clin Nutr; 2024 Mar; 119(3):599-627. PubMed ID: 38218319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects.
    Lerche S; Soendergaard L; Rungby J; Moeller N; Holst JJ; Schmitz OE; Brock B
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):500-6. PubMed ID: 19094067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of short-term continuous subcutaneous insulin infusion treatment on fasting glucagon-like peptide-1 concentrations in newly diagnosed type 2 diabetes.
    Huang X; Li S; Yang M; Fu X; Li H; Yan T; Liu Y; Chen L; Lan L; Li L; Zhong X
    Diabetes Res Clin Pract; 2018 Apr; 138():246-252. PubMed ID: 29408704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects.
    Jiménez A; Casamitjana R; Flores L; Delgado S; Lacy A; Vidal J
    Ann Surg; 2013 May; 257(5):894-9. PubMed ID: 23579541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.
    Cuthbertson J; Patterson S; O'Harte FP; Bell PM
    Metabolism; 2011 Jan; 60(1):52-6. PubMed ID: 20152998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous blood provides lower glucagon-like peptide-1 concentrations than arterialized blood in the postprandial but not the fasted state: Consequences of sampling methods.
    Chen YC; Edinburgh RM; Hengist A; Smith HA; Walhin JP; Betts JA; Thompson D; Gonzalez JT
    Exp Physiol; 2018 Sep; 103(9):1200-1205. PubMed ID: 29947441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
    Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
    Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.